Wall Street Experts
ver. ZuMIgo(08/25)
Panacea Biotec Limited
Rachunek Zysków i Strat
Przychody TTM (mln): 5 500
EBIT TTM (mln): -125
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
Rok finansowy |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2024 |
Przychód (mln) |
3,279 |
5,419 |
8,424 |
8,413 |
7,882 |
9,010 |
11,679 |
7,101 |
6,085 |
5,100 |
6,872 |
6,531 |
5,362 |
5,860 |
4,523 |
5,372 |
6,176 |
6,592 |
4,569 |
5,592 |
Przychód Δ r/r |
0.0% |
65.3% |
55.4% |
-0.1% |
-6.3% |
14.3% |
29.6% |
-39.2% |
-14.3% |
-16.2% |
34.7% |
-5.0% |
-17.9% |
9.3% |
-22.8% |
18.8% |
15.0% |
6.7% |
-30.7% |
22.4% |
Marża brutto |
110.6% |
99.8% |
98.5% |
100.1% |
105.7% |
47.6% |
49.8% |
51.1% |
56.7% |
55.2% |
59.2% |
67.0% |
68.1% |
64.1% |
55.2% |
67.5% |
63.0% |
54.5% |
39.0% |
51.9% |
EBIT (mln) |
526 |
1,133 |
2,294 |
2,030 |
-515 |
1,562 |
2,016 |
-2,553 |
-2,531 |
-1,110 |
-994 |
-189 |
-567 |
288 |
-1,178 |
116 |
328 |
-537 |
-1,060 |
-442 |
EBIT Δ r/r |
0.0% |
115.2% |
102.5% |
-11.5% |
-125.4% |
-403.4% |
29.1% |
-226.7% |
-0.9% |
-56.2% |
-10.4% |
-81.0% |
199.6% |
-150.7% |
-509.5% |
-109.8% |
183.4% |
-263.8% |
97.3% |
-58.3% |
EBIT (%) |
16.1% |
20.9% |
27.2% |
24.1% |
-6.5% |
17.3% |
17.3% |
-36.0% |
-41.6% |
-21.8% |
-14.5% |
-2.9% |
-10.6% |
4.9% |
-26.0% |
2.2% |
5.3% |
-8.1% |
-23.2% |
-7.9% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
426 |
556 |
1,007 |
1,038 |
1,446 |
970 |
1,210 |
969 |
964 |
850 |
1,731 |
1,847 |
1,798 |
38 |
36 |
EBITDA (mln) |
693 |
1,319 |
2,670 |
2,496 |
247 |
2,204 |
3,002 |
-776 |
-1,014 |
-726 |
656 |
1,295 |
1,051 |
912 |
-896 |
905 |
868 |
-17 |
-497 |
415 |
EBITDA(%) |
21.1% |
24.3% |
31.7% |
29.7% |
3.1% |
24.5% |
25.7% |
-10.9% |
-16.7% |
-14.2% |
9.6% |
19.8% |
19.6% |
15.6% |
-19.8% |
16.8% |
14.1% |
-0.3% |
-10.9% |
7.4% |
Podatek (mln) |
130 |
394 |
642 |
586 |
207 |
404 |
219 |
-542 |
-188 |
17 |
31 |
19 |
-110 |
99 |
77 |
166 |
20 |
3,710 |
466 |
30 |
Zysk Netto (mln) |
273 |
592 |
1,476 |
1,290 |
-660 |
724 |
1,447 |
-2,057 |
-2,343 |
-1,121 |
-1,065 |
-183 |
-562 |
-740 |
377 |
-1,943 |
-1,477 |
10,783 |
-332 |
-12 |
Zysk netto Δ r/r |
0.0% |
117.1% |
149.2% |
-12.6% |
-151.2% |
-209.7% |
99.8% |
-242.2% |
13.9% |
-52.1% |
-5.0% |
-82.8% |
207.3% |
31.6% |
-151.0% |
-614.9% |
-24.0% |
-830.1% |
-103.1% |
-96.5% |
Zysk netto (%) |
8.3% |
10.9% |
17.5% |
15.3% |
-8.4% |
8.0% |
12.4% |
-29.0% |
-38.5% |
-22.0% |
-15.5% |
-2.8% |
-10.5% |
-12.6% |
8.3% |
-36.2% |
-23.9% |
163.6% |
-7.3% |
-0.2% |
EPS |
3.91 |
9.57 |
23.84 |
19.51 |
-9.89 |
12.24 |
22.98 |
-33.58 |
-38.25 |
-18.31 |
-17.39 |
-2.99 |
-9.18 |
-12.08 |
6.16 |
-31.72 |
-24.11 |
176.05 |
-5.43 |
-0.19 |
EPS (rozwodnione) |
3.91 |
9.36 |
21.85 |
18.25 |
-9.26 |
11.46 |
22.98 |
-33.58 |
-38.25 |
-18.31 |
-17.39 |
-2.99 |
-9.18 |
-12.08 |
6.16 |
-31.72 |
-24.11 |
176.05 |
-5.43 |
-0.19 |
Ilośc akcji (mln) |
57 |
57 |
61 |
66 |
67 |
67 |
63 |
61 |
61 |
61 |
61 |
61 |
61 |
61 |
61 |
61 |
61 |
61 |
61 |
62 |
Ważona ilośc akcji (mln) |
57 |
59 |
67 |
71 |
71 |
71 |
63 |
61 |
61 |
61 |
61 |
61 |
61 |
61 |
61 |
61 |
61 |
61 |
61 |
62 |
Waluta |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |